BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28785085)

  • 21. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
    Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
    Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
    Wang Y; Nakayama M; Pitulescu ME; Schmidt TS; Bochenek ML; Sakakibara A; Adams S; Davy A; Deutsch U; Lüthi U; Barberis A; Benjamin LE; Mäkinen T; Nobes CD; Adams RH
    Nature; 2010 May; 465(7297):483-6. PubMed ID: 20445537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis.
    Durré T; Morfoisse F; Erpicum C; Ebroin M; Blacher S; García-Caballero M; Deroanne C; Louis T; Balsat C; Van de Velde M; Kaijalainen S; Kridelka F; Engelholm L; Struman I; Alitalo K; Behrendt N; Paupert J; Noel A
    Nat Commun; 2018 Dec; 9(1):5178. PubMed ID: 30518756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arf6 in lymphatic endothelial cells regulates lymphangiogenesis by controlling directional cell migration.
    Lin YC; Ohbayashi N; Hongu T; Katagiri N; Funakoshi Y; Lee H; Kanaho Y
    Sci Rep; 2017 Sep; 7(1):11431. PubMed ID: 28900118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolutionary Differences in the Vegf/Vegfr Code Reveal Organotypic Roles for the Endothelial Cell Receptor Kdr in Developmental Lymphangiogenesis.
    Vogrin AJ; Bower NI; Gunzburg MJ; Roufail S; Okuda KS; Paterson S; Headey SJ; Stacker SA; Hogan BM; Achen MG
    Cell Rep; 2019 Aug; 28(8):2023-2036.e4. PubMed ID: 31433980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia inhibits lymphatic thoracic duct formation in zebrafish.
    Ernens I; Lumley AI; Zhang L; Devaux Y; Wagner DR
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1129-1134. PubMed ID: 27916465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of lysosomal degradation in VEGF-C-induced down-regulation of VEGFR-3.
    Han KY; Chang JH; Dugas-Ford J; Alexander JS; Azar DT
    FEBS Lett; 2014 Nov; 588(23):4357-63. PubMed ID: 25281926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of Angiogenesis and Lymphangiogenesis in the Dual ex vivo Aortic and Thoracic Duct Assay.
    Wang S; Yamakawa M; Santosa SM; Chawla N; Guo K; Montana M; Hallak JA; Han KY; Ema M; Rosenblatt MI; Chang JH; Azar DT
    Protein Pept Lett; 2020; 27(1):30-40. PubMed ID: 31553284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis.
    Benest AV; Harper SJ; Herttuala SY; Alitalo K; Bates DO
    Cardiovasc Res; 2008 May; 78(2):315-23. PubMed ID: 18065770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ORAI1 Activates Proliferation of Lymphatic Endothelial Cells in Response to Laminar Flow Through Krüppel-Like Factors 2 and 4.
    Choi D; Park E; Jung E; Seong YJ; Hong M; Lee S; Burford J; Gyarmati G; Peti-Peterdi J; Srikanth S; Gwack Y; Koh CJ; Boriushkin E; Hamik A; Wong AK; Hong YK
    Circ Res; 2017 Apr; 120(9):1426-1439. PubMed ID: 28167653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells.
    Huang YH; Yang HY; Hsu YF; Chiu PT; Ou G; Hsu MJ
    Angiogenesis; 2014 Apr; 17(2):407-18. PubMed ID: 24048742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VEGF-C and TGF-β reciprocally regulate mesenchymal stem cell commitment to differentiation into lymphatic endothelial or osteoblastic phenotypes.
    Igarashi Y; Chosa N; Sawada S; Kondo H; Yaegashi T; Ishisaki A
    Int J Mol Med; 2016 Apr; 37(4):1005-13. PubMed ID: 26934950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
    Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
    Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer.
    Sun L; Duan J; Jiang Y; Wang L; Huang N; Lin L; Liao Y; Liao W
    Cancer Lett; 2015 Feb; 357(1):242-253. PubMed ID: 25444928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor.
    Zheng W; Tammela T; Yamamoto M; Anisimov A; Holopainen T; Kaijalainen S; Karpanen T; Lehti K; Ylä-Herttuala S; Alitalo K
    Blood; 2011 Jul; 118(4):1154-62. PubMed ID: 21566091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling.
    Geng X; Yanagida K; Akwii RG; Choi D; Chen L; Ho Y; Cha B; Mahamud MR; Berman de Ruiz K; Ichise H; Chen H; Wythe JD; Mikelis CM; Hla T; Srinivasan RS
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.
    García-Caballero M; Blacher S; Paupert J; Quesada AR; Medina MA; Noël A
    Br J Pharmacol; 2016 Jun; 173(12):1966-87. PubMed ID: 27018653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
    Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
    Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.